NM_001277115.2:c.9907A>G
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_001277115.2(DNAH11):c.9907A>G(p.Ile3303Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000428 in 1,610,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. I3303I) has been classified as Benign.
Frequency
Consequence
NM_001277115.2 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.000204  AC: 31AN: 152228Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.0000653  AC: 16AN: 245040 AF XY:  0.0000452   show subpopulations 
GnomAD4 exome  AF:  0.0000254  AC: 37AN: 1458462Hom.:  0  Cov.: 30 AF XY:  0.0000234  AC XY: 17AN XY: 725208 show subpopulations 
Age Distribution
GnomAD4 genome  0.000210  AC: 32AN: 152346Hom.:  0  Cov.: 33 AF XY:  0.000201  AC XY: 15AN XY: 74490 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia    Uncertain:2Benign:1 
- -
- -
The p.I3303V variant (also known as c.9907A>G), located in coding exon 60 of the DNAH11 gene, results from an A to G substitution at nucleotide position 9907. The isoleucine at codon 3303 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at